Assessing the role of stimulus probability on the Colavita visual dominance effect.

Neurosci Lett

Crossmodal Research Laboratory, Department of Experimental Psychology, University of Oxford, OX1 3UD, UK.

Published: May 2007

Participants presented with unimodal auditory (A), unimodal visual (V), or bimodal audiovisual stimuli (AV) in a task in which they have to identify the modality of the targets as rapidly as possible, fail to respond to the auditory component of bimodal targets significantly more often than they fail to respond to the visual component. In the majority of published studies on this phenomenon, known as the Colavita effect, the auditory, visual, and bimodal stimuli have been presented in the ratio 40A:40V:20AV. In the present study, we investigated whether the relatively low frequency with which the bimodal targets in previous studies have been presented may have contributed to participants' difficulty in responding to such targets correctly. We manipulated the bimodal target probability by presenting the stimuli in the ratios 20A:20V:60AV, in Experiment 1; 5A:5V:90AV, 25A:25V:50AV, and 45A:45V:10AV, in Experiment 2. A significant Colavita visual dominance effect was observed when the bimodal targets were presented on 60% of the trials or less. We suggest that increasing the frequency of bimodal targets may have provided an exogenous cue to performance, that reduced the necessity for endogenous attention when selecting the appropriate response to make to bimodal targets.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2007.03.032DOI Listing

Publication Analysis

Top Keywords

bimodal targets
20
colavita visual
8
visual dominance
8
bimodal
8
visual bimodal
8
fail respond
8
frequency bimodal
8
targets
7
visual
5
assessing role
4

Similar Publications

Molecular imaging has significantly advanced the detection and analysis of in vivo metabolic processes, while single-modal techniques remain limited. Dual-modal imaging, particularly positron emission tomography (PET)-based combinations has emerged as a powerful solution, offering enhanced capabilities through integration with magnetic resonance imaging (MRI) or near-infrared fluorescence (NIRF) imaging. This review highlights recent progress in PET-based dual-modal imaging, focusing on the development of various bimodal probes derived from antibodies, nanoparticles, and peptides, and key applications including image-guided surgery and disease assessment.

View Article and Find Full Text PDF

Objectives: Bimodal cochlear implant (CI) users vary in speech recognition outcomes. This variability may be influenced partly by the CI and contralateral hearing aid (HA) programming procedures, which can result in mismatches in latency and frequency. We assessed the performance of bimodal listeners when latency mismatches were corrected and analyzed how frequency mismatches influenced outcomes.

View Article and Find Full Text PDF

The assessment of early atherosclerosis (AS) via fluorescence imaging is crucial for advancing early diagnosis research. Abnormal inflammation biomarkers, including hypochlorous acid (HClO) and viscosity within mitochondria, have been closely linked to the pathogenesis of AS. However, current fluorescent probes predominantly rely on unimodal imaging that targets a single biomarker and lacks mitochondrial specificity, which can result in potential false signal readouts due to the complex intracellular environment.

View Article and Find Full Text PDF

Macrophage (Mph) polarization and functional activity play an important role in the development of inflammatory lung conditions. The previously widely used bimodal classification of Mph into M1 and M2 does not adequately reflect the full range of changes in polarization and functional diversity observed in Mph in response to various stimuli and disease states. Here, we have developed a model for the direct assessment of Mph from bronchial alveolar lavage fluid (BALF) functional alterations, in terms of phagocytosis activity, depending on external stimuli, such as exposure to a range of bacteria (, and ).

View Article and Find Full Text PDF

Activatable multifunctional nanoparticles present considerable advantages in cancer treatment by integrating both diagnostic and therapeutic functionalities into a single platform. These nanoparticles can be precisely engineered to selectively target cancer cells, thereby reducing the risk of damage to healthy tissues. Once localized at the target site, they can be activated by external stimuli such as light, pH changes, or specific enzymes, enabling precise control over the release of therapeutic agents or the initiation of therapeutic effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!